articleTop 1% cited
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Gynecologic Oncology · 2006 · Vol. 103(2) · pp. 559–564
D.S. Chi✉(Memorial Sloan Kettering Cancer Center)Eric Eisenhauer(Memorial Sloan Kettering Cancer Center)J. Lang(Memorial Sloan Kettering Cancer Center)Jae Huh(Memorial Sloan Kettering Cancer Center)Lisa B. Haddad(Memorial Sloan Kettering Cancer Center)Nadeem R. Abu‐Rustum(Memorial Sloan Kettering Cancer Center)Yukio Sonoda(Memorial Sloan Kettering Cancer Center)Douglas A. Levine(Memorial Sloan Kettering Cancer Center)Martee L. Hensley(Memorial Sloan Kettering Cancer Center)R.R. Barakat(Memorial Sloan Kettering Cancer Center)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometriosis Research and TreatmentMedicineStage (stratigraphy)Univariate analysisInternal medicineCohortOncologySurgeryCytoreductive surgeryMultivariate analysisDisease
MeSH terms
AdultAgedAged, 80 and overEpithelial CellsFemaleHumansMiddle AgedNeoplasm StagingOvarian NeoplasmsProspective StudiesGynecologic Surgical ProceduresSurvival RateNeoplasm, Residual
Citations
628
FWCI
28.13
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Cited by
CA125 and Ovarian Cancer: A Comprehensive Review
Cancers · 2020 · 584 citations
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · 590 citations
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Cancer · 2009 · 1,581 citations
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Gynecologic Oncology · 2013 · 421 citations
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Gynecologic Oncology · 2011 · 677 citations
References
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
Gynecologic Oncology · 1992 · 553 citations
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study
Gynecologic Oncology · 2003 · 413 citations
Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
Gynecologic Oncology · 1998 · 515 citations
Cancer Statistics, 2005
CA A Cancer Journal for Clinicians · 2005 · 5,459 citations
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
American Journal of Obstetrics and Gynecology · 1994 · 670 citations
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Gynecologic Oncology · 2004 · 321 citations
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Journal of Clinical Oncology · 2002 · 2,313 citations
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Journal of Clinical Oncology · 2003 · 2,051 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.